Free Pick from Jeff Brown: “Buy S.C.G .”
Jeff Brown picked Tesla in 2018 before it jumped 1,390%. He picked Nvidia before it jumped 3,545%. And he picked Bitcoin before it skyrocketed 22,750%.

And now he’s saying S.C.G. will be the next big tech play. He’s not the only one. Apple’s CEO even called it “the next big thing.”
Click here and get the name and ticker symbol!
Bruce D. Perkins, insider at Amedisys
Bruce D. Perkins Insider Alerts

Get notified the next time Bruce D. Perkins buys or sells Amedisys stock. Enter your email address below to get our daily insider buying and selling report.

Bruce D. Perkins Insider Information

Director of Amedisys
Mr. Perkins, the managing member for Perkins, Smith, & Associates, L.L.C. (“PSA”), based in Louisville, Kentucky, serves on the boards of three private healthcare companies. Mr. Perkins serves as a strategic executive for Baroma Midco, L.L.C.; a strategic advisor and executive coach for ChenMed, a Florida based MSO; a senior advisor for the Marwood Group; a senior advisor for US Imaging; and a consultant for Conviva, Interpreta, Devoted Health and Heath Care Service Corporation. He also serves on the Advisory Board of the University of Louisville College of Business. He previously served as chairman of the board of MCCI Group Holdings, a board member of Humana Health Plan of Puerto Rico, a strategic advisor for MCCI Group Holdings, and the treasurer of the American Association of PPOs (AAPPO). Mr. Perkins retired from Humana, Inc. (“Humana”) at the end of 2014 after a thirty-eight year career, most recently as President of Humana’s Healthcare Services Segment, which included the company’s pharmacy business, home care business, behavioral health business, physician businesses, and all clinical and provider network functions. Prior to his role as President of Healthcare Services, Mr. Perkins served as Regional Vice President and Divisional President for Humana health plans across multiple markets, and prior to the spin-off Humana’s hospital business, Mr. Perkins held multiple leadership positions including Divisional Vice President and hospital CEO, COO, and CFO. Mr. Perkins was appointed Chairman of the Compliance and Ethics Committee of our Board of Directors in June 2019.

What is Bruce D. Perkins' net worth?

The estimated net worth of Bruce D. Perkins is at least $3.95 million as of September 1st, 2021. Mr. Perkins owns 29,380 shares of Amedisys stock worth more than $3,951,904 as of January 20th. This net worth approximation does not reflect any other investments that Mr. Perkins may own. Learn More.

How do I contact Bruce D. Perkins?

The corporate mailing address for Mr. Perkins and other Amedisys executives is 3854 AMERICAN WAY SUITE A, BATON ROUGE LA, 70816. Amedisys can also be reached via phone at (225) 292-2031 and via email at [email protected]

Has Bruce D. Perkins been buying or selling shares of Amedisys?

Bruce D. Perkins has not been actively trading shares of Amedisys within the last three months. Most recently, Bruce D. Perkins sold 11,511 shares of the business's stock in a transaction on Wednesday, September 1st. The shares were sold at an average price of $183.00, for a transaction totalling $2,106,513.00. Following the completion of the sale, the director now directly owns 29,380 shares of the company's stock, valued at $5,376,540.

Who are Amedisys' active insiders?

Amedisys' insider roster includes Christopher Gerard (COO), Scott Ginn (CFO), David Kemmerly (Insider), Michael North (Insider), and Bruce Perkins (Director).

Are insiders buying or selling shares of Amedisys?

During the last year, Amedisys insiders bought shares 1 times. They purchased a total of 1,000 shares worth more than $141,250.00. During the last year, insiders at the health services provider sold shares 13 times. They sold a total of 22,875 shares worth more than $5,203,338.60. The most recent insider tranaction occured on November, 30th when Director Richard A Lechleiter bought 1,000 shares worth more than $141,250.00. Insiders at Amedisys own 1.8 % of the company.

Information on this page was last updated on 11/30/2021.

Bruce D. Perkins Insider Trading History at Amedisys

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/1/2021Sell11,511$183.00$2,106,513.0029,380View SEC Filing Icon  
See Full Table

Bruce D. Perkins Buying and Selling Activity at Amedisys

This chart shows Bruce D. Perkins's buying and selling at Amedisys by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Amedisys Company Overview

Amedisys logo
Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, and Personal Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The company was founded by William F. Borne in 1982 and is headquartered in Baton Rouge, LA.
Read More

Today's Range

Now: $134.51
Low: $133.91
High: $140.73

50 Day Range

MA: $156.12
Low: $133.02
High: $182.79

2 Week Range

Now: $134.51
Low: $132.79
High: $325.12


273,942 shs

Average Volume

375,790 shs

Market Capitalization

$4.39 billion

P/E Ratio


Dividend Yield



5 Tech Stocks to Buy Immediately
Eric Fry, one of America's top Investment Strategists, provides his latest report 5 Top Stocks for 2022.

You can't afford to miss out on the once in a decade chance to buy after the recent dip in the markets.
Download this hot-off-the-presses research report now. It’s yours FREE.